AKORN/ US0097281069 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
2023-11-08
ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Gu...
GlobeNewswire
2023-09-27
Ocuphire Pharma and Viatris Announce FDA Approval of RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.7...
GlobeNewswire
2022-02-03
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results
GlobeNewswire
2021-11-04
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results
GlobeNewswire
2021-10-18
Avelas makes senior appointments and provides update on pegloprastide Phase III clinical program
GlobeNewswire
2021-08-05
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 First Quarter Results
GlobeNewswire
2021-07-01
Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 202...
GlobeNewswire
2021-05-27
Prestige Announces Agreement to Expand Eye Care Offering with Acquisition of TheraTears
GlobeNewswire
2020-12-07
Oyster Point Pharma Strengthens Executive Leadership Team with the Appointment of Chief Medical and ...
GlobeNewswire
2020-06-22
Akorn Animal Health Announces Launch of Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophth...
GlobeNewswire
2020-06-08
Delisting of Securities of Centric Brands Inc.; Akorn, Inc.; and Scienjoy Holding Corporation from T...
GlobeNewswire
2019-11-14
Atlas Nanotech Targets the World’s Largest Consumer Health Products Companies to License the FirstEv...
GlobeNewswire
2019-10-14
Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
GlobeNewswire
2019-10-14
Akorn to Report Third Quarter 2019 Financial Results and Host Conference Call
GlobeNewswire
2019-08-26
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%